Literature DB >> 20493868

Up-regulation of annexin A2 in cholangiocarcinoma caused by Opisthorchis viverrini and its implication as a prognostic marker.

Ponlapat Yonglitthipagon1, Chawalit Pairojkul, Yaovalux Chamgramol, Jason Mulvenna, Banchob Sripa.   

Abstract

Cholangiocarcinoma (CCA), or cancer of the bile ducts, is primarily associated with infection with the liver fluke Opisthorchis viverrini in northeast Thailand. The disease is associated with late presentation, poses challenges for diagnosis and has a high mortality rate--features that highlight the need for tumor markers. At present, there are no specific tumor markers that can indicate the early stages and status of CCA. Proteomic analysis of the proteins expressed on the surface of tumor cells is particularly difficult since proteome-wide analysis of surface membrane proteins has thus far been hampered by the lack of effective strategies to profile hydrophobic membrane proteins. In this study, a sequential protein extraction was utilized to overcome this problem. Membrane protein was extracted from four CCA cell lines with different tumor forming capabilities. The non-tumor H69 biliary cell line was used as a control. Two-dimensional-PAGE followed by MALDI-TOF-MS was used to identify differentially expressed proteins. Among 20 up-regulated membrane proteins identified in the CCA cell lines was ANXA2, a participant in tumor invasion and metastasis in other cancers. Accordingly, ANXA2 was verified in human subjects by probing, using a commercial anti-mouse monoclonal antibody and a tissue microarray of CCA (301 diagnosed cases), where it was found to associate with one of several tumor progression stages as reflected by lymphatic invasion (P=0.014) and metastasis (P=0.026). Patients with high expression of ANXA2 had a significantly shorter survival time (P=0.011). ANXA2 expression in tumors may be useful for predicting the poor outcome of CCA patients. Copyright 2010 Australian Society for Parasitology Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20493868      PMCID: PMC3739719          DOI: 10.1016/j.ijpara.2010.05.002

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  36 in total

Review 1.  Opisthorchiasis control in Thailand.

Authors:  P Jongsuksuntigul; T Imsomboon
Journal:  Acta Trop       Date:  2003-11       Impact factor: 3.112

2.  Annexin II overexpression correlates with stromal tenascin-C overexpression: a prognostic marker in colorectal carcinoma.

Authors:  K Emoto; Y Yamada; H Sawada; H Fujimoto; M Ueno; T Takayama; K Kamada; A Naito; S Hirao; Y Nakajima
Journal:  Cancer       Date:  2001-09-15       Impact factor: 6.860

3.  Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma.

Authors:  K Emoto; H Sawada; Y Yamada; H Fujimoto; Y Takahama; M Ueno; T Takayama; H Uchida; K Kamada; A Naito; S Hirao; Y Nakajima
Journal:  Anticancer Res       Date:  2001 Mar-Apr       Impact factor: 2.480

4.  Identification of intrahepatic cholangiocarcinoma related genes by comparison with normal liver tissues using expressed sequence tags.

Authors:  Ai-Guo Wang; Sun Young Yoon; Jung-Hwa Oh; Yeo-Jin Jeon; Mirang Kim; Jeong-Min Kim; Sang-Soon Byun; Jin Ok Yang; Joo Heon Kim; Dae-Ghon Kim; Young-Il Yeom; Hyang-Sook Yoo; Yong Sung Kim; Nam-Soon Kim
Journal:  Biochem Biophys Res Commun       Date:  2006-05-11       Impact factor: 3.575

5.  Anxa2 plays a critical role in enhanced invasiveness of the multidrug resistant human breast cancer cells.

Authors:  Fei Zhang; Lin Zhang; Bin Zhang; Xiyin Wei; Yi Yang; Robert Z Qi; Guoguang Ying; Ning Zhang; Ruifang Niu
Journal:  J Proteome Res       Date:  2009-11       Impact factor: 4.466

Review 6.  Cholangiocarcinoma: lessons from Thailand.

Authors:  Banchob Sripa; Chawalit Pairojkul
Journal:  Curr Opin Gastroenterol       Date:  2008-05       Impact factor: 3.287

7.  [Annexin A2 expression in head and neck squamous cell carcinoma].

Authors:  Juan Pablo Rodrigo Tapia; Emma Pena Alonso; Juana M García-Pedrero; Manuel Florentino Fresno; Carlos Suárez Nieto; Reginald Owen Morgan; María Pilar Fernández
Journal:  Acta Otorrinolaringol Esp       Date:  2007 Jun-Jul

8.  Cell membrane proteomic analysis identifies proteins differentially expressed in osteotropic human breast cancer cells.

Authors:  Philippe Kischel; François Guillonneau; Bruno Dumont; Akeila Bellahcène; Verena Stresing; Philippe Clézardin; Edwin A De Pauw; Vincent Castronovo
Journal:  Neoplasia       Date:  2008-09       Impact factor: 5.715

Review 9.  A review and update on cholangiocarcinoma.

Authors:  Matthew J Olnes; Rodrigo Erlich
Journal:  Oncology       Date:  2004       Impact factor: 2.935

10.  Proteome characterization of a human urothelial cell line resistant to the bladder carcinogen 4-aminobiphenyl.

Authors:  Roberta Pastorelli; Federica Saletta; Donatella Carpi; Roberta Campagna; Carlo dell'Osta; Silvia Schiarea; Paolo Vineis; Luisa Airoldi; Giuseppe Matullo
Journal:  Proteome Sci       Date:  2007-05-03       Impact factor: 2.480

View more
  16 in total

1.  Milk fat globule epidermal growth factor 8 serves a novel biomarker of opisthorchiasis-associated cholangiocarcinoma.

Authors:  Zhiliang Wu; Thidarut Boonmars; Isao Nagano; Watcharin Loilome; Puangrat Yongvanit; Narong Khuntikeo; Phuangphaka Sadee Nielsen; Chawalit Paorojkul; Yuzo Takahashi; Yoichi Maekawa
Journal:  Tumour Biol       Date:  2014-03

2.  Candidate genes involving in tumorigenesis of cholangiocarcinoma induced by Opisthorchis viverrini infection.

Authors:  Zhiliang Wu; Thidarut Boonmars; Sirintip Boonjaraspinyo; Isao Nagano; Somchai Pinlaor; Anucha Puapairoj; Puangrat Yongvanit; Yuzo Takahashi
Journal:  Parasitol Res       Date:  2011-03-05       Impact factor: 2.289

3.  Prognostic significance of peroxiredoxin 1 and ezrin-radixin-moesin-binding phosphoprotein 50 in cholangiocarcinoma.

Authors:  Ponlapat Yonglitthipagon; Chawalit Pairojkul; Yaovalux Chamgramol; Alex Loukas; Jason Mulvenna; Jeffrey Bethony; Vajarabhongsa Bhudhisawasdi; Banchob Sripa
Journal:  Hum Pathol       Date:  2012-03-24       Impact factor: 3.466

4.  Increase of exostosin 1 in plasma as a potential biomarker for opisthorchiasis-associated cholangiocarcinoma.

Authors:  Jarinya Khoontawad; Nuttanan Hongsrichan; Yaovalux Chamgramol; Porntip Pinlaor; Chaisiri Wongkham; Puangrat Yongvanit; Chawalit Pairojkul; Narong Khuntikeo; Sittiruk Roytrakul; Thidarut Boonmars; Somchai Pinlaor
Journal:  Tumour Biol       Date:  2013-09-10

Review 5.  Cancer biomarker discovery for cholangiocarcinoma: the high-throughput approaches.

Authors:  Atit Silsirivanit; Kanlayanee Sawanyawisuth; Gregory J Riggins; Chaisiri Wongkham
Journal:  J Hepatobiliary Pancreat Sci       Date:  2014-02-12       Impact factor: 7.027

Review 6.  Immunotherapy as a treatment for biliary tract cancers: A review of approaches with an eye to the future.

Authors:  Alex B Blair; Adrian Murphy
Journal:  Curr Probl Cancer       Date:  2017-10-31       Impact factor: 3.187

7.  Proteomics-based identification of α-enolase as a potential prognostic marker in cholangiocarcinoma.

Authors:  Ponlapat Yonglitthipagon; Chawalit Pairojkul; Vajarabhongsa Bhudhisawasdi; Jason Mulvenna; Alex Loukas; Banchob Sripa
Journal:  Clin Biochem       Date:  2012-04-19       Impact factor: 3.281

Review 8.  Overexpression of ANXA2 predicts adverse outcomes of patients with malignant tumors: a systematic review and meta-analysis.

Authors:  Xinyu Liu; Ding Ma; Xiaoqian Jing; Bingrui Wang; Weiping Yang; Weihua Qiu
Journal:  Med Oncol       Date:  2014-12-05       Impact factor: 3.064

Review 9.  The tumorigenic liver fluke Opisthorchis viverrini--multiple pathways to cancer.

Authors:  Banchob Sripa; Paul J Brindley; Jason Mulvenna; Thewarach Laha; Michael J Smout; Eimorn Mairiang; Jeffrey M Bethony; Alex Loukas
Journal:  Trends Parasitol       Date:  2012-09-01

10.  Novel Potential Biomarkers for Opisthorchis viverrini Infection and Associated Cholangiocarcinoma.

Authors:  Nithikoon Aksorn; Sittiruk Roytrakul; Suthathip Kittisenachai; Kawin Leelawat; Pithi Chanvorachote; Supachai Topanurak; Shinjiro Hamano; Usa Lek-Uthai
Journal:  In Vivo       Date:  2018 Jul-Aug       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.